BRIEF published on 05/23/2025 at 09:10, 10 months 20 days ago BioNxt Solutions s'apprête à obtenir un brevet européen pour son système d'administration de médicaments Sclérose En Plaques Développement De Médicaments Solutions BioNxt Brevet Européen Administration Sublinguale
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Positive Outlook for NFON AG with Strategic Growth Initiatives Growth Strategy NFON AG Recurring Revenue Q1 Sales AI Initiatives
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Perspectives positives pour NFON AG avec des initiatives de croissance stratégique NFON AG Revenus Récurrents Stratégie De Croissance Ventes Du Premier Trimestre Initiatives En Matière D'IA
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Brödernas Group AB Postpones Annual Financial Statement Release Restructuring Process Financial Statement Delay Brödernas Group AB Richard Forsshéll Bonds Default
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Brödernas Group AB reporte la publication de ses états financiers annuels Groupe Brödernas AB Richard Forsshéll Processus De Restructuration Défaut De Paiement Des Obligations Retard Des États Financiers
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Alzchem Group AG Finalizes Succession Planning with New COO Appointment Chief Operating Officer Succession Planning Alzchem Group AG Specialty Chemicals Dr. Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Alzchem Group AG finalise sa planification de succession avec la nomination d'un nouveau directeur de l'exploitation Planification De La Relève Chef De L'exploitation Groupe Alzchem AG Produits Chimiques De Spécialité Dr Jürgen Sans
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Secarna Pharmaceuticals Unveils Promising SECN-15 Data at ASCO 2025 Cancer Therapy Clinical Trial Secarna Pharmaceuticals Antisense Oligonucleotide SECN-15
BRIEF published on 05/23/2025 at 09:05, 10 months 20 days ago Secarna Pharmaceuticals dévoile des données prometteuses sur le SECN-15 à l'ASCO 2025 Essai Clinique Secarna Pharmaceuticals Thérapie Contre Le Cancer Oligonucléotide Antisens SECN-15
BRIEF published on 05/23/2025 at 09:03, 10 months 20 days ago Grand City Properties Announces 2025 AGM Details Annual General Meeting Shareholders Real Estate Investment Luxembourg
Published on 04/11/2026 at 02:00, 2 days 5 hours ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 2 days 5 hours ago Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 2 days 6 hours ago Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/13/2026 at 07:00, 24 minutes ago The Burkhalter Group exceeds expectations once again by posting excellent results for the 2025 financial year
Published on 04/13/2026 at 07:00, 24 minutes ago Le Groupe Burkhalter surpasse une nouvelle fois les attentes et clôture l’exercice 2025 sur d’excellents résultats
Published on 04/13/2026 at 07:00, 24 minutes ago Swiss Re publishes its 2025 Financial Condition Report
Published on 04/13/2026 at 07:00, 24 minutes ago Twenty years of biosimilar medicines: a milestone that continues to transform patient access worldwide
Published on 04/13/2026 at 07:00, 24 minutes ago Data published in Nature Communications highlights unique Mechanism of Action of Alpibectir in combination with Ethionamide (AlpE)
Published on 04/11/2026 at 16:29, 1 day 14 hours ago Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 1 day 14 hours ago Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:35, 2 days 12 hours ago Déclaration des transactions sur actions propres
Published on 04/10/2026 at 18:26, 2 days 12 hours ago EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE
